29.10.2012
- Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter...
27.04.2012
- U.S. drugmaker Bristol-Myers Squibb said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries...
